Scientists probe blood cells for clues to scleroderma scarring
NCT ID NCT03816189
Summary
This study aimed to understand if a type of white blood cell called an eosinophil plays a role in causing the scarring (fibrosis) seen in scleroderma. Researchers compared blood and skin samples from 70 people, including scleroderma patients and healthy volunteers. The goal was to gather basic knowledge about the disease process, not to test a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Claude Huriez, CHU
Lille, France
Conditions
Explore the condition pages connected to this study.